BPG is committed to discovery and dissemination of knowledge
Observational Study
©The Author(s) 2024.
World J Gastrointest Oncol. Oct 15, 2024; 16(10): 4166-4176
Published online Oct 15, 2024. doi: 10.4251/wjgo.v16.i10.4166
Figure 1
Figure 1 Distribution of cases per institution. Over the 22-year period, 75 of 145 institutions (51.7%) reported zero cases, 55 institutions (37.9%) reported 1-4 cases, and 11 institutions (7.6%) reported 5-9 cases. Four institutions (2.8%) managed > 10 cases, with only one of these institutions reporting > 20 cases. The number of cases experienced varies greatly from facility to facility.
Figure 2
Figure 2 Questionnaire results. In the primary survey, 228 cases were enrolled, and 213 cases were finally enrolled in the secondary survey.
Figure 3
Figure 3 Diagnoses and procedures performed in the 213 cases. A: Diagnoses of the 213 cases. The most common type of pancreatic tumor was SPN [n = 164 (77.0%)], followed by pancreatoblastoma [n = 16 (7.5%)], pancreatic endocrine tumor [n = 14 (6.6%)], non-epithelial tumor [n = 9 (4.2%)], pancreatic cancer [n = 7 (3.3%)], and metastatic pancreatic tumor [n = 3 (1.4%)]; B: Procedures performed in the 213 cases. In total, 123 (57.7%) patients underwent distal pancreatectomy, of whom 49 underwent laparoscopic surgery. Furthermore, 44 (20.7%) patients underwent enucleation, of whom eight underwent laparoscopic surgery. In total, 32 (15.0%) patients underwent pancreaticoduodenectomy, of whom one underwent laparoscopic surgery. Moreover, one patient underwent total pancreatectomy, and the remaining 13 patients underwent other procedures. Of them, one patient had laparoscopic surgery.


Write to the Help Desk